SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
N-able entered into a Third Amendment to its Credit Agreement on June 16, 2026, adding a $75 million Delayed Draw Term Loan Facility with a six-month availability period. The proceeds may fund future permitted acquisitions and deferred consideration for the November 2024 Adlumin acquisition, making this a material financing event that enables M&A activity.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder vote results from AEON Biopharma's Annual Meeting of Stockholders held on June 17, 2026. The filing reports the final certified voting results for two proposals: (1) election of Class III directors Marc Forth and Seongsoo Park for three-year terms, and (2) ratification of KPMG LLP as independent auditor. Director elections and auditor ratifications are material governance matters affecting investor confidence in board composition and financial oversight.
View raw filing on EDGAR →Shareholders holding 77.45% of outstanding Class B Common Stock consented on June 17, 2026 to the adoption of an Amended and Restated Certificate of Incorporation that materially modifies the automatic conversion mechanics of Class B common stock by adding new Permitted Transferee categories (Qualifying Purpose Trusts and Qualifying Estate Planning Trusts) and exempting such trusts from automatic conversion upon death or permanent incapacity.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from MNTN's June 11, 2026 annual meeting of stockholders. The filing reports the election of three Class I directors (Joseph Kaiser, Tony Weisman, and Pali Bhat) and ratification of KPMG LLP as independent auditor, with detailed vote tallies for each proposal. This is a routine but material Item 5.07 disclosure required by SEC rules for annual meeting outcomes.
View raw filing on EDGAR →This 8-K Item 5.07 discloses the results of Amprius Technologies' June 11, 2026 annual meeting of stockholders, including voting outcomes for two proposals: election of directors Kathleen Bayless and Thomas M. Stepien, and ratification of Deloitte & Touche LLP as independent auditor. The filing presents vote tallies (For, Against/Withheld, Abstentions, Broker Non-Votes) and confirms both proposals passed, which is the core disclosure required under Item 5.07.
View raw filing on EDGAR →The exhibit announces the sale of Parque Logístico Lima Sur (PLS) to FIBRA Prime for US$145.0 million, generating US$85.0 million in net proceeds for LPA. This is a material disposition of a core asset that substantiates the company's book value (~$8.00 per share), demonstrates the company's vertically integrated platform, and catalyzes a strategic capital reallocation toward Mexico. The transaction is subject to customary regulatory approvals and closing conditions, consistent with Item 1.02 (Unregistered Sales of Equity Securities) or Item 2.01 (Completion of Acquisition or Disposition of Assets) disclosure requirements.
View raw filing on EDGAR →North Haven Net REIT sold an aggregate of 125,617 Class I shares and 15,966 Class F-I shares for approximately $2.94 million in total consideration to a feeder vehicle, with the sale exempt from registration under Section 4(a)(2) and Regulation D Rule 506. This is a classic unregistered private placement of equity securities, which Item 3.02 is designed to capture and which materially affects shareholder equity and ownership structure.
View raw filing on EDGAR →The press release announces the appointment of Maria Weaver as Chief Executive Officer and Board member of WeShop Holdings Limited, effective June 15, 2026. The disclosure explicitly states "its Board of Directors has appointed Maria Weaver as Chief Executive Officer and a member of the Board of Directors" and notes that she succeeds Paul Ellerbeck. This is a material executive appointment at the C-suite level, with detailed background on her 30-year career in media, entertainment, and technology, including senior roles at HBO, WMX, Comcast, and Interactive One.
View raw filing on EDGAR →The Trust discloses a material change in its distribution policy: it intends to make quarterly cash distributions of staking income to shareholders, with the first distribution expected in July 2026. This represents a significant operational and financial commitment that would affect investor returns and tax treatment. While the disclosure does not fit neatly into the standard taxonomy (it is neither an earnings release, executive change, M&A activity, nor a financial restatement), it is material to shareholders as it directly impacts the economic benefits of holding the shares and relies on specific IRS guidance (Revenue Procedure 2025-31) that could be modified or withdrawn.
View raw filing on EDGAR →John E. Gallagher has been appointed as Executive Vice President and Chief Financial Officer of CONMED Corporation, effective July 15, 2026, with a compensation package including a base salary of $650,000 and equity grants totaling approximately $3.8 million.
View raw filing on EDGAR →Stephen L. Johnson, Vice Chair and Chief Strategy Officer of American Airlines Group Inc., announced his retirement effective end of year 2026. This departure of a senior named executive officer is material to investors assessing the company's leadership continuity and strategic direction.
View raw filing on EDGAR →The Cincinnati Insurance Company's Chief Information Officer retired, as disclosed via a news release dated June 16, 2026. This departure of a named executive officer in a critical technology leadership role is material to investors given its impact on the registrant's management structure and operational continuity.
View raw filing on EDGAR →Bruce T. Crawford resigned from the Company's Board of Directors effective June 16, 2026, due to his appointment as president and Chief Executive Officer of AFCEA International. This is a clear director departure. While the filing notes no disagreement with the Company, the loss of a board member is material to investors assessing governance and board composition.
View raw filing on EDGAR →Jeremy M. Jacobs, Jr., CEO of Delaware North Companies, was elected to M&T Bank Corporation's Board of Directors on June 16, 2026. This is a clear executive appointment to the board of a major financial institution, which is material to investors assessing the company's governance and leadership composition.
View raw filing on EDGAR →Ford Motor Credit Company issued £300 million in senior notes (6.120% due 2032) under an effective S-3 registration statement. While this is a material debt issuance affecting the company's capital structure and financial obligations, it does not fit cleanly into the standard 8-K taxonomy—it is neither a covenant breach, going concern issue, nor a restatement. The disclosure is routine debt financing activity disclosed under Item 8.01 (Other Events), making "other_material" the most appropriate classification.
View raw filing on EDGAR →La-Z-Boy issued a news release on June 16, 2026 reporting financial results for the fiscal quarter ended April 25, 2026, disclosing quarterly financial performance.
View raw filing on EDGAR →Trinity Industries entered into a Third Amended and Restated Credit Agreement on June 12, 2026, replacing its existing credit facility with a $600 million unsecured revolving line of credit maturing in 2031 (or 2028 if senior notes are not repaid). This material refinancing restructures the company's debt facilities and capital structure.
View raw filing on EDGAR →Air T, Inc. completed a material acquisition of Arena Aviation Partners B.V. for $21.75 million in cash consideration on June 10, 2026, with contingent consideration potentially reaching $23.0 million. The transaction also involved a significant reorganization of the Crestone Asset Management platform through CAP as the platform vehicle, including a $6.2 million acquisition of the MRC Parties' 10% interest in CAM and $21.7 million in capitalization contributions.
View raw filing on EDGAR →Air T, Inc. created a direct financial obligation through Amendment No. 6 to the Alerus Credit Agreement and Overline Note. The specific nature of the obligation—whether involving a covenant modification, debt restructuring, or other arrangement—cannot be definitively determined without full visibility into the amendment details.
View raw filing on EDGAR →This disclosure reports OCC approval of a bank merger application whereby Webster Bank, National Association will merge into Santander Bank, and references the broader acquisition of Webster Financial Corporation by Banco Santander, S.A. This constitutes a material acquisition/change of control event. Although filed under Item 8.01 (Other Events), the substance is a major M&A milestone—regulatory approval of the bank-level merger component of the transaction.
View raw filing on EDGAR →The Board appointed Douglas Neal as an independent director effective immediately, increasing the Board size to seven members. Mr. Neal was also appointed to the Audit Committee and Compensation Committee.
View raw filing on EDGAR →Isabella Bank Corporation entered into an Equity Distribution Agreement with Piper Sandler & Co. to issue and sell up to $30 million of common stock through an "at the market offering" under Rule 415. This is a dilutive equity issuance that would materially affect existing shareholders through potential dilution. The $30 million offering size and explicit authorization for ATM sales and private placements are hallmarks of a dilutive_issuance event.
View raw filing on EDGAR →The filing discloses the appointment of Dr. Matt Cohen as a director of Arrowhead Pharmaceuticals effective June 12, 2026. While the disclosure includes compensatory details (a sign-on grant of restricted stock units valued at $887,000), the principal action is the appointment itself. The extensive background information on Dr. Cohen's 25+ years of healthcare investing experience and his roles at major institutions (JP Morgan, Vida Ventures) underscores the materiality of adding a qualified director to the board.
View raw filing on EDGAR →This Item 5.07 discloses the results of the 2026 Annual Meeting of Stockholders, including voting outcomes on three proposals: election of three directors (Mark A. Frantz, Carol J. Lindstrom, and Arshad Matin), advisory approval of executive compensation, and ratification of Deloitte & Touche LLP as independent auditor. The filing presents vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07 for shareholder meeting results.
View raw filing on EDGAR →The filing discloses cash tender offers by Arch Capital's wholly-owned subsidiaries to repurchase outstanding senior notes totaling up to $417.9 million in principal amount. While technically a debt repurchase rather than a traditional M&A transaction, tender offers for material amounts of debt securities constitute material capital structure activity that affects the registrant's financial position and obligations. The magnitude and specificity of the transaction (pricing announcement, increased maximum amount) indicate materiality to investors.
View raw filing on EDGAR →STMicroelectronics announces a US$1.5 billion dual-tranche offering of convertible bonds (2031 and 2033 tranches) and the early redemption of its 2027 Convertible Bonds. This is a material creation of new direct financial obligations through debt issuance, approved by both the managing board and supervisory board, with settlement expected June 23, 2026. The offering proceeds will be used for general corporate purposes including redemption of existing debt.
View raw filing on EDGAR →STMicroelectronics announced the pricing of a US$1.5 billion dual-tranche offering of senior unsecured convertible bonds (US$750 million due 2031 and US$750 million due 2033). This is a material creation of direct financial obligations. The press release explicitly states the pricing terms, conversion prices, maturity dates, and settlement date (June 23, 2026), and notes that proceeds will be used for general corporate purposes including early redemption of existing convertible bonds. This is a classic debt issuance disclosure.
View raw filing on EDGAR →Sleep Number Corporation has filed for Chapter 11 bankruptcy protection and entered into a debtor-in-possession (DIP) financing agreement providing $260 million in committed financing to support operations during the reorganization process.
View raw filing on EDGAR →Rocket Companies closed a $1.5 billion debt offering ($900M 2031 Notes and $600M 2034 Notes) on June 16, 2026, pursuant to an Indenture with U.S. Bank Trust Company. While this is technically a debt issuance rather than a traditional M&A transaction, Item 1.01 encompasses "Entry into a Material Definitive Agreement," and the Indenture constitutes a material definitive agreement. The proceeds are earmarked for debt refinancing (repaying 2026 and 2028 Rocket Mortgage Notes), making this a material capital structure event. However, this is more accurately characterized as a debt financing event than M&A; the closest fit in the taxonomy is ma_activity given the materiality and the Item 1.01 classification, though other_material would also be defensible.
View raw filing on EDGAR →MSC Industrial announced a cash dividend of $0.87 per share declared by its Board of Directors. While dividend declarations are routine corporate actions, this disclosure is material to investors as it affects shareholder returns and capital allocation. The event does not fit neatly into the more specific taxonomy categories (it is neither an earnings release, executive change, M&A activity, nor a financial restatement), making "other_material" the most appropriate classification.
View raw filing on EDGAR →The filing discloses execution of an Agreement and Plan of Merger whereby Simulations Plus will merge with a subsidiary of Altaris, LLC, with the Company surviving as a wholly owned subsidiary of Parent. This constitutes a material acquisition/change of control transaction. The disclosure explicitly references the Merger Agreement and announces the transaction via press release, which is the hallmark of Item 1.01 (M&A activity), even though it is filed under Item 7.01 (Regulation FD Disclosure).
View raw filing on EDGAR →SDG&E and SoCalGas filed 2028 General Rate Case applications with the CPUC on June 15, 2026, requesting revenue requirements of $3,760 million (SDG&E) and $5,096 million (SoCalGas) for the 2028 test year, with attrition adjustments through 2031. This is a material regulatory filing that affects authorized revenue recovery and rates, but does not fit neatly into the standard 8-K taxonomy categories. While regulatory decisions are inherently material to utility investors, this disclosure is primarily informational about a pending CPUC proceeding rather than a discrete event like a covenant breach, impairment, or M&A activity.
View raw filing on EDGAR →B. Scot Ebron was appointed to the office of President of Shore United Bank, N.A. on June 15, 2026, and simultaneously appointed to the Bank's Board of Directors. This is a material executive appointment of a named officer to a senior leadership position at the Company's wholly-owned subsidiary, affecting the organizational structure and governance of the registrant.
View raw filing on EDGAR →Urban One entered into a new employment agreement with CFO Peter D. Thompson establishing comprehensive compensatory arrangements including a $750,000 base salary, $333,333 signing bonus, annual performance bonuses up to $300,000, a $850,000 completion bonus contingent on remediation of material weaknesses, and stock-based compensation grants totaling over $1.8 million through January 6, 2029.
View raw filing on EDGAR →Urban One held its 2026 Annual Meeting of Stockholders on June 11, 2026, with voting results on the election of six directors (Terry L. Jones, Brian W. McNeill, Catherine L. Hughes, Alfred C. Liggins III, B. Doyle Mitchell Jr., and D. Geoffrey Armstrong), approval of the 2026 Equity and Performance Incentive Plan, and ratification of PricewaterhouseCoopers LLP as independent auditor.
View raw filing on EDGAR →Columbia Sportswear held its Annual Meeting of shareholders with 49.6 million shares (97% of outstanding) voted. Results included election of all 10 directors with strong majorities, ratification of Deloitte & Touche LLP as auditor, approval of executive compensation, approval of the Amended and Restated 2020 Stock Incentive Plan (increasing authorized equity from 4.5 million to 9 million shares), and rejection of a proxy access proposal.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Chipotle's 2026 annual meeting of shareholders held on June 11, 2026. The filing presents final voting tallies for three proposals: election of ten directors (all elected with strong majorities), advisory approval of executive compensation, and ratification of Ernst & Young LLP as independent auditor. These are material governance events that affect investor understanding of board composition and shareholder sentiment on compensation and audit oversight.
View raw filing on EDGAR →Western Copper & Gold has entered into an amended and restated investor rights agreement with Mitsubishi Materials, extending the partnership through November 30, 2028, contingent on Mitsubishi Materials acquiring 1.2 million common shares through open market purchases to return its ownership to approximately 5%. This represents a material strategic transaction involving a significant shareholder's increased equity stake and formalized governance rights, affecting the registrant's capital structure and control relationships.
View raw filing on EDGAR →This Item 5.07 filing discloses the results of the June 12, 2026 annual meeting of shareholders, including voting outcomes on four proposals: election of three directors, advisory approval of executive compensation, frequency of future compensation votes, and amendment to the Articles of Incorporation regarding board size. The disclosure of shareholder vote results at an annual meeting is the textbook definition of Item 5.07 and the shareholder_vote_results event type.
View raw filing on EDGAR →The filing discloses the closing of Natural Gas Services Group's acquisition of Flatrock Compression Holdings LLC, announced via a conference call on June 15, 2026. Although filed under Item 7.01 (Regulation FD Disclosure) rather than the typical Item 1.01 or 2.01, the substance is a material acquisition completion that would materially affect a reasonable investor's assessment of the registrant's business and financial position.
View raw filing on EDGAR →Prestige Consumer Healthcare completed the acquisition of the Breathe Right® brand and related assets from Foundation Consumer Brands for $1.045 billion in cash on June 12, 2026, financed through a new Term Loan Credit Agreement with an additional $95 million draw available for the previously announced LaCorium Health acquisition expected to close in Q2 fiscal 2027.
View raw filing on EDGAR →This press release announces a significant order intake of more than €26 million since mid-May 2026, with year-to-date orders of approximately €43 million through June 15, 2026. The disclosure highlights material business development across multiple customers and regions (China, Taiwan, South Korea, Europe) for advanced PCB manufacturing equipment (InfinityLine Production Equipment for HDI-ML and mSAP applications). While this is a material operational and commercial milestone reflecting strong market momentum and customer investment, it does not fit the specific event categories of earnings release (no financial results), M&A activity, or other defined types. The order intake announcement is a discrete operational/commercial event material to investor assessment of the company's business trajectory and market position.
View raw filing on EDGAR →The filing discloses a proposed all-stock merger of equals between Huntsman Corporation and Olin Corporation pursuant to an Agreement and Plan of Merger entered into on June 15, 2026. This is a material acquisition/change of control transaction announced via joint press release on June 16, 2026, with detailed disclosure of the merger structure, regulatory filing plans, and shareholder approval requirements. The transaction clearly qualifies as M&A activity under Item 1.01 or 2.01 standards.
View raw filing on EDGAR →PTC Therapeutics announced the pricing of a $500 million convertible notes offering (with an additional $50 million option), which will result in shares of common stock issuable upon conversion. The notes are unregistered securities sold pursuant to an exemption from Securities Act registration. This is a material dilutive issuance that raises substantial capital and creates future equity dilution through conversion rights.
View raw filing on EDGAR →Kanzhun granted 550,498 RSU share awards to 45 employees on June 15, 2026, pursuant to the Post-IPO Share Scheme, with vesting schedules ranging from 2–4 years, performance targets covering 84.87% of awards, and clawback provisions.
View raw filing on EDGAR →Palvella Therapeutics held its Annual Meeting on June 16, 2026, with stockholders voting on six proposals: election of three Class III directors (Jenkins, Davis, Doux), ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, advisory frequency vote on compensation (approved annually), approval of an amendment to the 2024 Equity Incentive Plan increasing authorized shares by 750,000, and adjournment authority. All proposals passed.
View raw filing on EDGAR →The exhibit announces completion of Fairfax's acquisition of Kennedy Wilson Holdings, Inc. for US$10.90 per share in cash pursuant to a Merger Agreement. This is a material acquisition transaction where Fairfax holds a majority economic interest in the acquired company, along with a US$1.3 billion term loan facility and a stand-by guarantee arrangement. The completion of a major M&A transaction is a core material event under Item 1.01/2.01 of the 8-K taxonomy.
View raw filing on EDGAR →The disclosure announces FDA acknowledgment of a BLA resubmission for ONS-5010 (bevacizumab-vikg) with a Class 1 review designation and a 60-day PDUFA goal date of July 29, 2026. This is a material regulatory milestone for a biopharmaceutical company's lead product candidate, but does not fit neatly into the more specific event categories (it is neither a final approval/denial, a going-concern issue, nor a material impairment). The event would affect a reasonable investor's assessment of the company's regulatory progress and near-term catalysts.
View raw filing on EDGAR →The filing discloses a blackout period triggered by the "previously announced acquisition of TopBuild Corp." pursuant to a merger agreement dated April 18, 2026, with QXO, Inc. and its subsidiaries. While Item 5.04 addresses the technical blackout notice requirement, the material event underlying this disclosure is the M&A activity—the proposed merger itself—which is explicitly referenced as the reason for the blackout period and would materially affect investor assessment of the company's future.
View raw filing on EDGAR →The exhibit announces the completion of Nebius's acquisition of Eigen AI, a leading inference and model optimization company. The transaction was announced May 1, 2026, and closed June 10, 2026, following receipt of required regulatory approvals. This is a material acquisition completion that would affect a reasonable investor's assessment of the registrant's strategic direction and financial position.
View raw filing on EDGAR →